Murli Krishna Pharma Private Limited - Company Profile

It is a pharma private limited company based in Pune, Maharashtra, India, established in 2004.

2004 Pune, Maharashtra, India Active

Last Updated: February 03, 2026

About Murli Krishna Pharma Private Limited

Murli Krishna Pharma Private Limited, a active private limited company, was established on 02 April 2004 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230PN2004PTC206917. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹32.50 Cr and a paid-up capital of ₹5.39 Cr.

It upholds a compliant status. Employing 218 professional, Its leadership includes Nithyagovind (Nominee Director), Satya Ramani Vadlamani (Managing Director), Venkat Murli Krishna Vadlamani (Director). Past directors included Sau Chun Fung, Nithyagovind, Eshwar Rao Vadlamani. It holds ₹81.98 Cr open charges and ₹13.76 Cr settled loans. Its latest AGM occurred on 31 December 2025, with the balance sheet filed on 31 March 2025. It is based at D-98, Ranjangaon Midc, Tal Shirur,, Pune, Maharashtra, 412209.

Company Details

CIN/LLPIN
U24230PN2004PTC206917
Registration Number
206917
Incorporation Date
02 April 2004
Authorized Capital
₹32.50 Cr
Paid-Up Capital
₹5.39 Cr
ROC Code
Roc Pune
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 32.50 Cr as on 03-02-2026
Paid Up Capital ₹ 5.39 Cr as on 03-02-2026
Company Age 21 Year, 11 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 81.98 Cr as on 03-02-2026
Satisfied Charges ₹ 13.76 Cr as on 03-02-2026
Revenue Growth **** -21.37% (FY 2025)
Profit Growth **** -73.76% (FY 2025)
Ebitda **** -36.59% (FY 2025)
Net Worth 1.98% (FY 2025)
Total Assets **** 7.16% (FY 2025)

Comprehensive Company Insights

Explore comprehensive insights into Murli Krishna Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Murli Krishna Pharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Nithyagovind	Nominee Director	27 May 2020	Current
Satya Ramani Vadlamani	Managing Director	02 Apr 2004	Current
Venkat Murli Krishna Vadlamani	Director	15 Jul 2024	Current
Vijay Shastri Kalyanasundaram	Director	02 Apr 2004	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	28 Aug 2018	Past
Pramod Abcsdd	Additional Director	28 May 2020	Past
Pramod Abcsdd	Director	02 Mar 2013	Past
Pramod Abcsdd	Director	16 Apr 2015	Past
Pramod Abcsdd	Director	01 Apr 2006	Past
Pramod Abcsdd	Director	26 May 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Murli Krishna Pharma.

Murli Krishna Pharma Private Limited, for the financial year ended 2025, experienced significant reduction in revenue, with a 21.37% decrease. The company also saw a substantial fall in profitability, with a 73.76% decrease in profit. The company's net worth moved up by a moderate rise of 1.98%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-21.37%

*******

Revenue from Operations

*******

-21.63%

*******

Total Assets

*******

7.16%

*******

Profit or Loss

*******

-73.76%

*******

Net Worth

*******

1.98%

*******

EBITDA

*******

-36.59%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Murli Krishna Pharma?

In 2024, Murli Krishna Pharma had a promoter holding of 19.60% and a public holding of 80.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹819,844,998.00

Satisfied Charges

₹137,600,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 60.68 Cr
Others : 20.00 Cr
Axis Bank Limited : 1.30 Cr

Latest Charge Details

Date	Lender	Amount	Status
22 Aug 2025	Hdfc Bank Limited	₹3.00 M	Open
28 Jun 2024	Others	₹10.00 Cr	Open
28 Jun 2024	Others	₹10.00 Cr	Open
04 Sep 2023	Axis Bank Limited	₹1.30 Cr	Open
09 May 2023	Hdfc Bank Limited	₹2.30 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Murli Krishna Pharma?

Murli Krishna Pharma has a workforce of 218 employees as of Sep 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Murli Krishna Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Murli Krishna Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Murli Krishna Pharma

Recent Activity within the Organization

Annual General Meeting

Murli Krishna Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2025 as per latest MCA records. was recorded as a recent event.
31 Dec 2025
Charges

Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 101178916 was registered on 22 Aug 2025. was documented.
22 Aug 2025
Balance Sheet

Progress on Murli Krishna Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.
31 Mar 2025
Director Appointment

The activity Venkat Murli Krishna Vadlamani was appointed as a Director was appointed as a Director on 15 Jul 2024 & has been associated with this company since 1 year 8 months . was completed.
15 Jul 2024
Charges

The activity A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100950333 was registered on 28 Jun 2024. was completed.
28 Jun 2024
Charges

The activity A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100950346 was registered on 28 Jun 2024. was completed.
28 Jun 2024

Explore recent activity and updates - View Recent Activity